Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Merck Millipore Launches Vegetable-Based Contact Agar

Published: Wednesday, September 12, 2012
Last Updated: Tuesday, September 11, 2012
Bookmark and Share
Ready-to-use plate determines a surface's microbial count.

Merck Millipore has announced the launch of Vegetable Contact Agar + LTHTh - ICRplus, a ready-to-use plate ideal for environmental monitoring of isolators and clean rooms.

The plate is designed to determine the microbial count present on a surface, and because its agar is of non-animal origin, the device minimizes the risk of animal spongiform encephalopathy (TSE/BSE) transmission.

The Vegetable Contact Agar + LTHTh - ICRplus determines a surface's count of bacteria, yeasts and mold by promoting efficient microbial growth under both aerobic and anaerobic incubation conditions.

A series of neutralizers will counteract a vast variety of disinfectants, allowing microorganisms to grow even if the surface of the agar contains residual amounts of disinfectant. The device has a long shelf life and can be stored at room temperature.

The new contact plate provides a safe surface monitoring method because the Vegetable Contact Agar + LTHTh - ICRplus is composed of high quality peptones of non-animal origin. This eliminates the potential contamination risk of TSE/BSE transmissible agents.

"Our new vegetable-based contact agar is designed to ensure safety by reducing contamination risks during the manufacture of biopharmaceutical drugs and other medicinal products," said Dr. Yvonne Hochheimer, Project Manager, Merck Millipore.

Dr. Hochheimer continued, "It will complete further our portfolio of vegetable-based products such as the ready-to-use Vegetable Peptone Broth for media fills and increase the choice of high quality products for our customers."


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck Millipore Announces Incoming CEO and President
Udit Batra, Ph.D. will be responsible for the organization’s strategic direction to drive growth and product innovation as well as oversight of the worldwide operations.
Tuesday, April 15, 2014
Merck Millipore Announces Exclusive Agreement with Julphar Diabetes
Collaboration to offer non-animal origin, recombinant human insulin as cell culture media supplement.
Wednesday, August 08, 2012
Scientific News
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
Yeast Cells Use Signaling Pathway to Modify Their Genomes
Researchers at the Babraham Institute and Cambridge Systems Biology Centre, University of Cambridge have shown that yeast can modify their genomes to take advantage of an excess of calories in the environment and attain optimal growth.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
New Measurements Reveal Differences Between Stem Cells for Treating Retinal Degeneration
By growing two types of stem cells in a “3-D culture” and measuring their ability to produce retinal cells, a team lead by St. Jude Children’s Research Hospital researchers has found one cell type to be better at producing retinal cells.
Researchers Identify Critical Genes Responsible for Brain Tumor Growth
After generating new brain tumor models scientists have identified the role of a family of genes underlying tumor growth in a wide spectrum of high grade brain tumors.
Growing Spinal Disc Tissue
Scientists develop new method for growing spinal disc tissue in the lab for combating chronic back pain.
A New Path Towards a Universal Flu Vaccine
New research suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective and efficient vaccines against this ever-mutating virus.
Potential New Class of Cancer Drugs
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
Human Trials of Manufactured Blood Within Two Years
The first human trials of lab-produced blood to help create better-matched blood for patients with complex blood conditions has been announced by NHS Blood and Transplant.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!